Trial Profile
Safety and efficacy of Tipiracil/trifluridine (TAS-102) in patients with refractory metastatic colorectal cancer
Status:
Completed
Phase of Trial:
Phase I
Latest Information Update: 09 Feb 2016
Price :
$35
*
At a glance
- Drugs Tipiracil/trifluridine (Primary)
- Indications Colorectal cancer
- Focus Adverse reactions; Therapeutic Use
- Sponsors Taiho Pharmaceutical
- 09 Feb 2016 New trial record